63.4 2.1% 99.0 3.2% 35.6 56.2% Net Profit Attributable to Equity Holders of the Company 115.2 3.9% -187.3 -6.0% -302.4 -262.6% Revenue Analysis The total revenue in Q1/2018 was equivalent to 3,112.8
Company can issue the replacement debentures or use a working capital to repay those debentures. Shareholders’ Equity As of February 28, 2021, total shareholders’ equity amounted to 17,380 million baht, a
Company’s operation. The Company also has the debentures totaling 3.4 billion baht that will mature within the next 12 months, which the Company can issue the replacement debentures or use a working capital
can issue the replacement debentures or use a working capital to repay those debentures. Shareholders’ Equity As of August 31, 2021, total shareholders’ equity amounted to 18,454 million baht, an
debentures totaling 3,800 million baht that will mature within 12 months, which the Company can issue new debentures or use a working capital to repay as scheduled. Shareholders’ Equity As of February 28, 2022
debentures or use a working capital to repay as scheduled. In addition, the resolution of the Annual General Meeting of Shareholders for the year 2022 held on June 24, 2022 had approved the issuance and
Company’s operation. The Company also has the debentures totaling 3,800 million baht that will mature within 12 months, which the Company can issue new debentures or use a working capital to repay as
operation. The Company also has the debentures totaling 1,000 million baht that will mature within 12 months, which the Company can issue new debentures or use a working capital to repay as scheduled
., Ltd. registered in Thailand with initial registered capital of THB 700 million, in which the company holds 100% share, to conduct businesses regarding bio-based products business operation, and to